Kalaris Therapeutics, Inc.
KLRS
$3.54
$0.164.73%
NASDAQ
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.97M | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 1.22M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 102.18M | -- | |||
|
|
|||||
| Total Current Assets | 102.18M | -- | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 910.00K | -- | |||
| Total Assets | 103.09M | -- | |||
|
|
|||||
| Total Accounts Payable | 2.37M | -- | |||
| Total Accrued Expenses | 4.54M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 230.00K | -- | |||
| Total Other Current Liabilities | 230.00K | -- | |||
| Total Current Liabilities | 7.14M | -- | |||
|
|
|||||
| Total Current Liabilities | 7.14M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 32.08M | -- | |||
| Total Liabilities | 39.22M | -- | |||
|
|
|||||
| Common Stock & APIC | 190.63M | -- | |||
| Retained Earnings | -126.76M | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 63.87M | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 63.87M | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 63.87M | -- | |||
|
|
|||||